Protein crosslinked films replace rigid electrodes with stretchable, transparent ionic conductors for biodegradable electronics and biocompatible interfaces.
Medium-long-chain fatty acid ligands plus sequential ion exchange remove mismatched and modified albumins to improve purity and stability.
Targeted albumin mutations improve bacterial expression yield by increasing solubility, thermostability, and ligand binding without animal sourcing.
Aminoguanidine and medium-chain fatty acids curb albumin polymerization and contaminant binding, improving chromatographic purity and yield.
CRISPR knockout of cell wall genes and EXG1/SPR1 overexpression in K. phaffii improves recombinant human albumin secretion and yield.